Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Severstal reports for 9 months of 2024 by IFRS

10/21/24 CHMF

Rusagro's revenues grew by 20% in 9 months

10/21/24 AGRO

Polyus reported for 9 months of 2024 by RAS

10/21/24 PLZL

Europlan reported a slowdown in new business growth rate

10/21/24 LEAS

Softline completed the second stage of Noventiq receipts exchange

10/21/24 SOFL

Russneft reported for 9 months of 2024 by RAS

10/18/24 RNFT

LSR sales for 9 months decreased by 21%

10/18/24 LSRG

Fesco launched a container train from Syktyvkar to Vladivostok

10/18/24 FESH

Transneft reported for 9 months of 2024 by RAS

10/18/24 TRNFP

Lukoil abandoned plans to buy back its shares from non-residents

10/18/24 LKOH